K PHOS NEUTRAL- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, monohydra

Land: USA

Språk: engelsk

Kilde: NLM (National Library of Medicine)

Aktiv ingrediens:

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F) (PHOSPHATE ION - UNII:NK08V8K8HR, SODIUM CATION - UNII:LYR4M0NH37), POTASSIUM PHOSPHATE, MONOBASIC (UNII: 4J9FJ0HL51) (PHOSPHATE ION - UNII:NK08V8K8HR, POTASSIUM CATION - UNII:295O53K152), SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) (PHOSPHATE ION - UNII:NK08V8K8HR, SODIUM CATION - UNII:LYR4M0NH37)

Tilgjengelig fra:

Beach Products, Inc.

INN (International Name):

Sodium Phosphate, Dibasic, Anhydrous

Sammensetning:

Sodium Phosphate, Dibasic, Anhydrous 852 mg

Administreringsrute:

ORAL

Resept typen:

PRESCRIPTION DRUG

Indikasjoner:

K-PHOS® NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S.RDA) of phosphorus for adul t s and children over 4 years of age. This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Produkt oppsummering:

White, film coated, scored capsule-shaped tablet with the name BEACH and the number 1125 imprinted on each tablet. Bottles of 100 (NDC 0486-1125-01) and bottles of 500 (NDC 0486-1125-05) tablets. Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). [See USP] Dispense in tight, light-resistant containers with child-resistant closures.

Autorisasjon status:

unapproved drug other

Preparatomtale

K PHOS NEUTRAL- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM
PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC,
MONOHYDRATE TABLET, COATED
BEACH PRODUCTS, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
K-PHOS® NEUTRAL
PHOSPHORUS SUPPLEMENT
_Rx ONLY_
DESCRIPTION
_Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155
mg monobasic_
_potassium phosphate, and the equivalent of 130 mg monobasic sodium
phosphate_
_monohydrate. Each tablet yields approximately 250 mg of phosphorus,
298 mg of_
_sodium (13.0 mEq) and 45 mg of potassium (1.1 mEq). The components of
K-PHOS®_
_NEUTRAL have the following chemical names and molecular formulae:_
_Dibasic Sodium Phosphate, Anhydrous _
_Molecular Formula: Na2HPO4, Molecular Weight: 141.96._
_Monobasic Potassium Phosphate _
_Molecular Formula: KH2PO4, Molecular Weight: 136.09._
_Monobasic Sodium Phosphate, Monohydrate _
_Molecular Formula:NaH2PO4.H2O, Molecular Weight: 137.98._
_Inactive Ingredients: Lactose monohydrate, povidone, white coating
(hydroxypropyl_
_methylcellulose, titanium dioxide, maltodextrin, triacetin, glycerol
triacetate, polyethylene_
_glycol, sodium citrate, and stearic acid), sodium starch glycolate,
and magnesium_
_stearate._
CLINICAL PHARMACOLOGY
_Phosphorus has a number of important functions in the biochemistry of
the body. The_
_bulk of the body's phosphorus is located in the bones, where it plays
a key role in_
_osteoblastic and osteoclastic activities. Enzymatically catalyzed
phosphate-transfer_
_reactions are numerous and vital in the metabolism of carbohydrate,
lipid and protein,_
_and a proper concentration of the anion is of primary importance in
assuring an orderly_
_biochemical sequence. In addition, phosphorus plays an important role
in modifying_
_steady-state tissue concentrations of calcium. Phosphate ions are
important buffers of_
_the intracellular fluid, and also